EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer’s Disease

Alexandra Horvath, Patrick Quinlan, Carl Eckerström, N David Åberg, Anders Wallin, Johan Svensson

Journal of Alzheimer's Disease · 2024

DOI: 10.3233/jad-231026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Alexandra Horvath und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Alzheimer Disease, Cognitive Dysfunction, White Matter. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulin-like growth factor-I (IGF-I) regulates myelin, but little is known whether IGF-I associates with white matter functions in subjective and objective mild cognitive impairment (SCI/MCI) or Alzheimer’s disease (AD).

Objective

To explore whether serum IGF-I is associated with magnetic resonance imaging – estimated brain white matter volumes or cognitive functions.

Methods

In a prospective study of SCI/MCI (n = 106) and AD (n = 59), we evaluated the volumes of the total white matter, corpus callosum (CC), and white matter hyperintensities (WMHs) as well as Mini-Mental State Examination (MMSE), Trail Making Test A and B (TMT-A/B), and Stroop tests I–III at baseline, and after 2 years.

Results

IGF-I was comparable in SCI/MCI and AD (113 versus 118 ng/mL, p = 0.44). In SCI/MCI patients, the correlations between higher baseline IGF-I and greater baseline and 2-year volumes of the total white matter and total CC lost statistical significance after adjustment for intracranial volume and other covariates. However, after adjustment for covariates, higher baseline IGF-I correlated with better baseline scores of MMSE and Stroop test II in SCI/MCI and with better baseline results of TMT-B and Stroop test I in AD. IGF-I did not correlate with WMH volumes or changes in any of the variables.

Conclusions

Both in SCI/MCI and AD, higher IGF-I was associated with better attention/executive functions at baseline after adjustment for covariates. Furthermore, the baseline associations between IGF-I and neuropsychological test results in AD may argue against significant IGF-I resistance in the AD brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor IAlzheimer DiseaseCognitive DysfunctionWhite MatterMagnetic Resonance ImagingBrainNeuropsychological TestsHumansMaleFemaleAgedAged, 80 and overCognitionProspective StudiesMiddle AgedOrgan SizeMental Status and Dementia TestsInsulin-Like Peptides

Stichwörter der Autor:innen

Alzheimer’s diseaseattentioncorpus callosumexecutive functioninsulin-like growth factor-Imagnetic resonance imagingmild cognitive impairmentspeedsubjective mild cognitive impairmentwhite matter hyperintensities

Substanzen

Insulin-Like Growth Factor IInsulin-Like Peptides

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Acute Medicine and Geriatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Internal Medicine, Skaraborg Central Hospital, Skövde, Sweden.

Zitieren

APA

Horvath, A., Quinlan, P., Eckerström, C., Åberg, N. D., Wallin, A., & Svensson, J. (2024). The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-231026

Vancouver

Horvath A, Quinlan P, Eckerström C, Åberg ND, Wallin A, Svensson J. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-231026

BibTeX
@article{Horvath2024,
  author = {Horvath, Alexandra and Quinlan, Patrick and Eckerström, Carl and Åberg, N David and Wallin, Anders and Svensson, Johan},
  title = {The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  doi = {10.3233/jad-231026}
}
Kostenlos starten →